These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3857136)

  • 1. Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis.
    Johnson CA; Zimmerman SW; Bayer W; Craig WA
    Clin Nephrol; 1985 Mar; 23(3):120-4. PubMed ID: 3857136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
    Burgess ED; Blair AD
    Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of cefotaxime after i.v. and i.p. administration in patients treated with continual ambulatory peritoneal dialysis (CAPD)].
    Matousovic K; Morávek J; Vítko S; Prát V; Horcicková M; Novák Z; Kuklík R; Krebs V; Janků J
    Cas Lek Cesk; 1984 Jun; 123(22):678-80. PubMed ID: 6331672
    [No Abstract]   [Full Text] [Related]  

  • 5. [Absorption of ceftizoxime from peritoneal dialysate and its pharmacokinetics in chronic kidney failure patients].
    Gao S; Li P; Liu GL; Wang SX; Chui RL; Yang JP
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):377-80. PubMed ID: 1456067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis.
    Gross ML; Somani P; Ribner BS; Raeader R; Freimer EH; Higgins JT
    Clin Pharmacol Ther; 1983 Nov; 34(5):673-80. PubMed ID: 6313276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis.
    Bouchet JL; Albin H; Quentin C; de Barbeyrac B; Vinçon G; Martin-Dupont P; Potaux L; Aparicio M
    Clin Nephrol; 1988 Jan; 29(1):35-40. PubMed ID: 3383462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of ceftizoxime with and without probenecid].
    Adam D; Timmler R
    Arzneimittelforschung; 1982; 32(4):416-9. PubMed ID: 6285937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Petersen J; Stewart RD; Catto GR; Edward N
    Nephron; 1985; 40(1):79-82. PubMed ID: 4000338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
    Hasegawa H; Imada A; Horiuchi A; Nishii Y; Fukushima M; Kurokawa E
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tissue concentration of ceftizoxime in the lung].
    Adam D; König J
    Arzneimittelforschung; 1983; 33(3):427-9. PubMed ID: 6307319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefmenoxime kinetics during continuous ambulatory peritoneal dialysis.
    Sica DA; Polk RE; Kerkering TM; Patterson P; Baggett J
    Eur J Clin Pharmacol; 1986; 30(6):713-7. PubMed ID: 3464435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of peritonitis due to continuous ambulatory peritoneal dialysis using a single daily intraperitoneal dose of 1g cefotiam].
    Ragnaud JM; Roche-Bezian MC; Marceau C; Demothes-Mainard F; Albin H; Prevost D; Wone C
    Pathol Biol (Paris); 1986 May; 34(5):512-6. PubMed ID: 3534734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transperitoneal movement and pharmacokinetics of cefotiam and cefsulodin in patients on continuous ambulatory peritoneal dialysis.
    Brouard R; Tozer TN; Merdjan H; Guillemin A; Baumelou A
    Clin Nephrol; 1988 Oct; 30(4):197-206. PubMed ID: 3214965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elimination of aluminum via continuous ambulatory peritoneal dialysis].
    Passlick J; Wilhelm M; Busch T; Grabensee B; Ohnesorge FK
    Dtsch Med Wochenschr; 1989 Jan; 114(1):9-13. PubMed ID: 2910699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.